Nebraska Health Information Initiative (NEHII) recognized as CMS Submitter for Quality Payment Program for 2021
News provided by
Share this article
Share this article
OMAHA, Neb., Dec. 21, 2020 /PRNewswire/ Nebraska Health Information Initiative (NEHII) is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) recognized NEHII as a Qualified Clinical Data Registry (QCDR) for 2021.
A QCDR is a CMS-approved entity that collects clinical data for the purpose of quality improvement regarding the care furnished to patients. QCDRs are one of several available reporting mechanisms for eligible clinicians and groups for the Merit-Based Incentive Payment System (MIPS), Primary Care First (PCF) and other CMS Quality Payment Program (QPP) payment models.
Friday, December 18, 2020
This Week’s Dose
Congress is close to a deal to fund the government as well as provide further coronavirus (COVID-19) relief, although work will continue over the weekend. The Food and Drug Administration (FDA) approved the first COVID-19 vaccine for emergency use, and is expected to
Congress
Congress Expected to Finalize $900 Billion in COVID-19 Relief. House and Senate lawmakers are reportedly nearing a deal on COVID-19 relief and stimulus legislation that resembles a proposal introduced by the bipartisan bicameral working group earlier this week. The bill is expected to include direct grants to states and localities and funding for the Centers for Disease Control and Prevention (CDC) to support vaccine distribution, along with funding for states for testing and contact tracing efforts, and additional money for the Provider Relief Fund (PRF). The bill is also expected to include additional funding for the Paycheck Protection Program to
Building a Better Clinician Value-Based Payment Program in Medicare jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.
Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, HHS issued a final rule intended to govern the administrative dispute process in the 340B Drug Pricing Program. Read more about the rule and other news below.
I. Regulations, Notices & Guidance
On December 8, 2020, the Food & Drug Administration (FDA) issued guidance entitled,
Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. This draft guidance describes best practices to help minimize medication errors and otherwise avoid adoption of proprietary names that contribute to violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and its implementing regulations. The draft guidance also describes the framework FDA uses i
Highlights
The Centers for Medicare & Medicaid Services (CMS) has published the Calendar Year (CY) 2021 Final Rule for the Medicare Physician Fee Schedule (MPFS), which contains updates to the Quality Payment Program (QPP). The MPFS dictates Medicare rates and policies under Part B, while the QPP implements two value-based payment programs: the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs).
Among notable changes, CMS has proposed to make permanent certain telehealth changes that have been implemented in response to the COVID-19 public health emergency (PHE), confirmed the evaluation and management (E/M) documentation guidelines and payment changes finalized in the 2020 MPFS, and delayed the MIPS Value Pathway (MVP) until the 2022 performance period or later.